104 related articles for article (PubMed ID: 8993572)
1. Increased liver-specific expression of catalase in transgenic mice.
Nilakantan V; Li Y; Spear BT; Glauert HP
Ann N Y Acad Sci; 1996 Dec; 804():542-53. PubMed ID: 8993572
[No Abstract] [Full Text] [Related]
2. Sequential alterations in the micro-localization of catalase in mouse liver after treatment with hypolipidemic drugs.
Klucis E; Crane D; Masters C
Mol Cell Biochem; 1984 Nov; 65(1):73-82. PubMed ID: 6521730
[TBL] [Abstract][Full Text] [Related]
3. Three hypolipidemic drugs increase hepatic palmitoyl-coenzyme A oxidation in the rat.
Lazarow PB
Science; 1977 Aug; 197(4303):580-1. PubMed ID: 195342
[TBL] [Abstract][Full Text] [Related]
4. Microbody proliferation in liver induced by nafenopin, a new hypolipidemic drug: comparison with CPIB.
Reddy J; Svoboda D; Azarnoff D
Biochem Biophys Res Commun; 1973 May; 52(2):537-43. PubMed ID: 4711169
[No Abstract] [Full Text] [Related]
5. Protein phosphorylation by peroxisome proliferators: species-specific stimulation of protein kinases and its role in PP-induced transcriptional activation.
Motojima K; Passilly P; Jannin B; Latruffe N
Ann N Y Acad Sci; 1996 Dec; 804():413-23. PubMed ID: 8993560
[No Abstract] [Full Text] [Related]
6. Zonal heterogeneity of peroxisome proliferation in rat liver.
Fahimi HD; Beier K; Lindauer M; Schad A; Zhan J; Pill J; Rebel W; Völkl A; Baumgart E
Ann N Y Acad Sci; 1996 Dec; 804():341-61. PubMed ID: 8993555
[No Abstract] [Full Text] [Related]
7. Peroxisomal beta-oxidation and catalase activities in fetal rat liver: effect of maternal treatment with clofibrate.
Cibelli A; Stefanini S; Ceru MP
Cell Mol Biol; 1988; 34(2):191-205. PubMed ID: 3378247
[No Abstract] [Full Text] [Related]
8. Effect of AY-25,712 and other lipid-lowering agents on liver catalase and liver carnitine acetyltransferase in rats.
Kallai-Sanfacon MA; Cayen MN; Dubuc J; Greselin E; Dvornik D
Proc Soc Exp Biol Med; 1983 Jul; 173(3):367-71. PubMed ID: 6867010
[TBL] [Abstract][Full Text] [Related]
9. Hepatic catalase is not essential for the hypolipidemic action of peroxisome proliferators.
Reddy JK; Moody DE; Azarnoff DL; Rao MS
Proc Soc Exp Biol Med; 1977 Apr; 154(4):483-7. PubMed ID: 859854
[No Abstract] [Full Text] [Related]
10. Increase in hepatic carnitine acetyltransferase activity associated with peroxisomal (microbody) proliferation induced by the hypolipidemic drugs clofibrate, nafenopin, and methyl clofenapate.
Moody DE; Reddy JK
Res Commun Chem Pathol Pharmacol; 1974 Nov; 9(3):501-10. PubMed ID: 4445568
[No Abstract] [Full Text] [Related]
11. Immunocytochemical analysis of soluble epoxide hydrolase and catalase in mouse and rat hepatocytes demonstrates a peroxisomal localization before and after clofibrate treatment.
Hollinshead M; Meijer J
Eur J Cell Biol; 1988 Aug; 46(3):394-402. PubMed ID: 3181162
[TBL] [Abstract][Full Text] [Related]
12. Induction of peroxisomal enzymes in rat liver by the hypolipidemic agent LK-903.
Hayashi H; Hino S; Yamasaki F; Watanabe T; Suga T
Biochem Pharmacol; 1981 Jul; 30(13):1817-22. PubMed ID: 7271869
[No Abstract] [Full Text] [Related]
13. Response of microbodies in Morris hepatoma 9618A to clofibrate.
Tsukada H; Mochizuki Y; Itabashi M; Gotoh M; Morris HP
J Natl Cancer Inst; 1975 Jul; 55(1):153-8. PubMed ID: 169361
[TBL] [Abstract][Full Text] [Related]
14. Response of liver and kidney catalase to alpha-p-chlorophenoxyisobutyrate (clofibrate) in C57B1/6J male mice of different ages.
Baird MB; Zimmerman JA; Massie HR; Samis HV
Gerontologia; 1974; 20(3):169-78. PubMed ID: 4461328
[No Abstract] [Full Text] [Related]
15. Hepatic effect of two hypolipidemic drugs in rats.
Magnusson G; Magnusson O
Exp Pathol (Jena); 1977; 13(2-3):180-7. PubMed ID: 913535
[TBL] [Abstract][Full Text] [Related]
16. Changes in lipid metabolizing enzymes of hepatic subcellular fractions from rats treated with tiadenol and clofibrate.
Berge RK; Bakke OM
Biochem Pharmacol; 1981 Aug; 30(16):2251-6. PubMed ID: 7295339
[No Abstract] [Full Text] [Related]
17. Polydispersity of rat liver peroxisomes induced by the hypolipidemic and carcinogenic agent clofibrate.
Flatmark T; Christiansen EN; Kryvi H
Eur J Cell Biol; 1981 Apr; 24(1):62-9. PubMed ID: 7238535
[TBL] [Abstract][Full Text] [Related]
18. Identification of a catalase-negative sub-population of peroxisomes induced in mouse liver by clofibrate.
Klucis E; Crane DI; Hughes JL; Poulos A; Masters CJ
Biochim Biophys Acta; 1991 Jul; 1074(2):294-301. PubMed ID: 1676600
[TBL] [Abstract][Full Text] [Related]
19. Activation of catalase and other enzymes by corn oil intake.
Iritani N; Ikeda Y
J Nutr; 1982 Dec; 112(12):2235-9. PubMed ID: 7143106
[TBL] [Abstract][Full Text] [Related]
20. Clofibrate treatment increases stearoyl-CoA desaturase mRNA level and enzyme activity in mouse liver.
Diczfalusy U; Eggertsen G; Alexson SE
Biochim Biophys Acta; 1995 Dec; 1259(3):313-6. PubMed ID: 8541340
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
